Tectonic Therapeutics TECX Income Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| $63.49M+53.5% | $41.37M-0.1% | $41.43M-42.6% | $72.19M-13.1% | ||
| $20.55M+23.4% | $16.65M+19.7% | $13.91M-58.2% | $33.25M-6.9% | ||
| $84.04M+44.8% | $58.02M+4.8% | $55.34M-47.5% | $105.43M-11.3% | ||
| -$84.04M-44.8% | -$58.02M-4.8% | -$55.34M+47.5% | -$105.43M+11.3% | ||
| $63K-40.6% | $106K-30.3% | $152K— | —— | ||
| $11.12M+31,657% | $35K-98.3% | $2M— | —— | ||
| -$72.92M-25.8% | -$57.98M— | —— | —— | ||
| $17.14M+12.3% | $15.27M— | —— | $0— | ||
| -$74.15M-27.9% | -$57.98M-35.4% | -$42.82M+59.6% | -$105.89M+11.1% | ||
| -$4.05— | —— | -$22.40-829% | -$2.41+13.6% | ||
| -$82.66M-46.6% | -$56.37M-4.4% | -$53.98M+48.1% | -$104.01M+11.4% | ||
| -$84.04M-44.8% | -$58.02M-4.8% | -$55.34M+47.5% | -$105.43M+11.3% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Is Tectonic Therapeutics profitable?
- Tectonic Therapeutics is not currently profitable: it reported a net loss of $83.5M over the trailing twelve months.
- What is Tectonic Therapeutics's earnings per share?
- Tectonic Therapeutics's diluted EPS over the trailing twelve months is $-4.46.
- Where does Tectonic Therapeutics's income statement data come from?
- Every line is extracted from Tectonic Therapeutics's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.